Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XLKYQ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
IKS-01
|
|||||
| Synonyms |
IKS01; IKS 01
Click to Show/Hide
|
|||||
| Organization |
Iontas, Inc.; Iksuda Therapeutics Ltd.; Femtogenix Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Lung cancer [ICD11:2C25]
Clinical candidate
Ovarian cancer [ICD11:2C73]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Isumab01
|
Antibody Info | ||||
| Antigen Name |
Folate receptor alpha (FOLR1)
|
Antigen Info | ||||
| Payload Name |
FGX2-62
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Iksuda's proprietary PermaLink conjugation technology
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.